OHLCX Market Research
Delayed

DXCM

Dexcom develops continuous glucose monitoring systems for people with diabetes, providing real-time glucose data.

−2.01 (−2.51%) Nov 20, 2026 19:55 ET Delayed
Open
80.20
High
81.58
Low
78.18
Prev close
80.19
Volume
4M
Avg vol 10
4M

Today · Market closed · opens Mon 9:30 AM

Price

DXCM chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 78.18

Strong sellNeutralStrong buy
Sell
score −0.28 · 18 signalling
2Buy
9Neutral
7Sell

Leaning sell. 7 of 18 signals point down against 2 up, carried by momentum and trend. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 12).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −0.85 · Signal −0.73 · Hist −0.12
Sell
ADX 14
Weak trend, −DI slightly ahead
ADX 12.23 · +DI 17.89 · −DI 21.88
Neutral
Parabolic SAR 0.02, 0.2
Above price, 11.85 over the close
90.03
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 81.10 · Base 83.38 · A 85.86 · B 87.34
Sell

Momentum

RSI 14
Mid-range, no extreme
41.15
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 0.00 · %D 14.28
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 16.64 · %D 30.23
Neutral
Williams %R 14
Oversold zone, falling
−100.00
Neutral
CCI 14
Below −100, still falling
−105.39
Neutral
MFI 14
Below midpoint, not oversold
36.61
Neutral
ROC 12
Price down 11.65% over 12 bars
−11.65%
Sell
AO 5, 35
Below zero and falling
−1.06
Sell
TRIX 18
Below zero
−0.141
Sell
KST 10/15/20/30, 3
Above its signal line
KST −28.07 · Signal −29.96
Buy

Volatility

Bollinger 20, 2
Lower half, %b 0.17
Up 86.42 · Mid 81.43 · Low 76.44
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 86.12 · Mid 81.68 · Low 77.24
Neutral

Volume

VWAP 345-bar
Close 8.2% above VWAP
72.25
Buy
Force Index 1
Negative, sellers in control
−9.3M
Sell
ATR
2.92
3.74% of close
A/D Line
−3.9M
cumulative
OBV
72.3M
cumulative
Volume Profile
67.85 – 70.60
POC · bull 195.0M · bear 240.2M · 45 / 55
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

1.28%

Change in value over the past month.

3 month return

-12.89%

Change in value over the last three months.

Max drawdown

22.61%

Largest fall from a peak to the low that followed.

Standard deviation

39.27%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.70

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.21

Annualised return against the maximum drawdown.

About

DXCM summary

Loading summary…

Questions

DXCM, answered

What factors affect the stock price of DXCM?

Factors include product adoption, regulatory approvals, competition, and overall market conditions in the healthcare sector.

How can I buy DXCM stock?

You can purchase DXCM stock through a brokerage account or with the help of a financial advisor.

Where can I find news about Dexcom?

News can be found on financial news websites, industry journals, and Dexcom’s official press releases.

What are Dexcom’s core values?

Dexcom values innovation, integrity, and a patient-centric approach in its operations.

Does Dexcom pay dividends?

Dexcom does not currently pay dividends; the company reinvests its earnings into growth initiatives.

What is Dexcom’s strategy for market growth?

Dexcom focuses on expanding its product offerings, increasing market penetration, and enhancing partnerships with healthcare providers.

What do analysts think about DXCM stock?

Analysts provide ratings and insights on DXCM; check investment research platforms for up-to-date evaluations.

What is the current market capitalization of Dexcom?

Market capitalization changes regularly; check financial websites for the most current information on Dexcom.

What new products is Dexcom launching?

For updates on new products, visit Dexcom’s official website or check their press releases.

How does Dexcom manage regulatory compliance?

Dexcom follows strict regulatory guidelines and engages with health authorities to ensure compliance with industry standards.

News

DXCM in the news

Improve Your DXCM Trading Now

Empower your trading with OHLCX.com. Our comprehensive platform delivers precise analysis and strategic insights for DXCM, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.